MENLO
PARK, Calif., July 31,
2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL),
a healthcare company whose mission is to detect cancer early when
it can be cured, announced today that it will issue financial
results for the second quarter 2024 following the close of market
on Tuesday, Aug. 13, 2024. Following
the release, company management will host a webcast and conference
call at 1:30 p.m. PT / 4:30 p.m. ET to discuss results and business
progress.
Second Quarter 2024 Webcast and Conference Call
Details
A link to the live webcast and recorded replay will
be available at the investor relations section of GRAIL's website
at investors.grail.com.
Please register for the live event at
https://grail-q2-financial-results-2024.open-exchange.net/.
To ensure timely connection, please register for the
teleconference and join the webcast at least ten minutes before the
scheduled start of the call. The live webcast and recorded replay
are open to all interested parties.
About GRAIL
GRAIL is a healthcare company whose
mission is to detect cancer early, when it can be cured. GRAIL is
focused on alleviating the global burden of cancer by using the
power of next-generation sequencing, population-scale clinical
studies, and state-of-the-art machine learning, software, and
automation to detect and identify multiple deadly cancer types in
earlier stages. GRAIL's targeted methylation-based platform can
support the continuum of care for screening and precision oncology,
including multi-cancer early detection in symptomatic patients,
risk stratification, minimal residual disease detection, biomarker
subtyping, treatment and recurrence monitoring. GRAIL is
headquartered in Menlo Park, CA
with locations in Washington,
D.C., North Carolina, and
the United Kingdom.
For more information, visit grail.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/grail-to-announce-second-quarter-2024-financial-results-302211341.html
SOURCE GRAIL, Inc.